Locations:
Search
Who is at risk? What tests should be ordered?
$1.1M award expands follow-up to six years with focus on clinical endpoints
Guidance for the 5% to 20% of patients with suboptimal response or tolerability
Diagnosis and treatment of MOG antibody-associated disease
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Care guidelines have been crucial to progress in TBI care over the past 25 years
Mounting evidence of possible shared genetic predisposition
Recently launched first-of-kind study aims to address an unmet therapeutic need
Biomarker promises a practical way to reduce misdiagnoses
AHA scientific statement offers best practices to improve care for high-risk populations
Relapse rates were lower with oral or infusion therapy after initial injectable DMT
Advertisement
Advertisement